Management of head and neck sarcomas: a tertiary referral institution's 20-year experience

Christopher Thompson, Justin Yeo, Iain Nixon, Brendan Conn, Donald Salter, Ioanna Nixon

Research output: Contribution to conferencePoster


Introduction: Head and neck (H&N) sarcomas are histologically diverse and constitute only 1 % of all H&N malignancies. Standard management involves either chemoradiation or surgical excision with adjuvant therapy, but despite therapeutic advances, prognosis remains poor. Methods: Retrospective review of all patients with H&N sarcoma treated at the Edinburgh Cancer Research Centre between 1999-2019 (n=55) was performed. Patients were divided into paediatric (
Original languageEnglish
Publication statusPublished - 26 Feb 2020
EventBritish Sarcoma Group Conference 2020 - Glasgow, United Kingdom
Duration: 26 Feb 202027 Feb 2020


ConferenceBritish Sarcoma Group Conference 2020
CountryUnited Kingdom


  • head sarcoma
  • neck sarcoma
  • cancer management

Cite this